Minimal Change Disease

Quantify proteinuria and assess urine sediment, serum albumin, creatinine, and blood pressure at presentation. A nephrotic pattern usually has proteinuria greater than 3.5 g per 24 hours with relatively inactive urine sediment; red-cell casts or dysmorphic erythrocytes instead favor a nephritic glomerular process requiring a different diagnostic pathway.PubMedPubMedChronic Kidney Disease - StatPearls - NCBI Bookshelf

Perform kidney biopsy in adults with suspected MCD because clinical nephrotic syndrome cannot reliably distinguish MCD from focal segmental glomerulosclerosis (FSGS), membranous nephropathy, diabetic kidney disease, amyloidosis, or other causes. Histologic MCD requires correlation across light microscopy, immunofluorescence, and electron microscopy: minimal light-microscopic change, absent immune-complex staining, and diffuse foot-process effacement without electron-dense deposits.spj science+2spj scienceAutoantibodies Targeting Vinculin Reveal Novel Insight into the Mechanisms of Autoimmune PodocytopathiesPubMedManagement of Adult Minimal Change Disease - PMC - NIHPubMedNephrotic Syndrome - StatPearls - NCBI Bookshelf

If biopsy identifies segmental sclerosis, reassess for primary versus secondary FSGS rather than applying an MCD regimen automatically. Podocytopathies can show MCD or FSGS lesions, and treatment response with resolution of proteinuria is prognostically important; persistent proteinuria is associated with poor renal prognosis in primary podocytopathies.NatureNaturePodocytopathies | Nature Reviews Disease Primers

Assess for AKI at every initial and relapse presentation with serial serum creatinine, volume assessment, blood pressure, and urine output. AKI occurs in approximately 20% to 25% of adults with MCD; risk is greater with older age, hypertension, arteriosclerosis on biopsy, and high-grade proteinuria. Acute tubular necrosis has been reported in up to 60% of affected adults, and recovery may occasionally be incomplete.PubMedPubMedManagement of Adult Minimal Change Disease - PMC - NIH

Use diuretics for symptomatic edema and reassess volume status and kidney function during decongestion. Renin-angiotensin system antagonists can reduce proteinuria and slow fibrosis progression in podocytopathies; adjunctive management may include statins, infection prophylaxis, and anticoagulation when clinically indicated by the nephrotic state and patient-specific risk.NatureNaturePodocytopathies | Nature Reviews Disease Primers

Before high-dose glucocorticoids, document weight, blood pressure, and examination findings for infection and systemic disease; serial weight is useful for tracking edema response.PubMedPubMedNephrotic Syndrome - StatPearls - NCBI Bookshelf

For the initial adult episode of MCD, use prednisone or prednisolone 1 mg/kg as a single daily dose (maximum 80 mg) or 2 mg/kg as a single alternate-day dose (maximum 120 mg).PubMedPubMedThe Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome The KDIGO 2021 glomerular-disease guideline includes a dedicated adult MCD chapter, and the subsequent KDIGO update judged that chapter still current because no new evidence had been identified to revise it.Kidney International+1Kidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...Kidney InternationalKDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)

If complete remission occurs, continue the tolerated high dose for a minimum of 4 weeks. If complete remission has not occurred, high-dose therapy may be continued for up to 16 weeks; do not declare early treatment failure solely because adult remission is slower than pediatric remission.PubMedPubMedThe Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome

After remission, taper glucocorticoids slowly, with total taper duration of up to 6 months after remission. During the taper, follow proteinuria, creatinine, blood pressure, weight, and adverse effects of prolonged corticosteroid exposure.PubMed+1PubMedThe Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic SyndromePubMedNephrotic Syndrome - StatPearls - NCBI Bookshelf

For frequently relapsing or steroid-dependent adult MCD, cyclophosphamide has extensive clinical experience as a steroid-sparing option. After remission is regained with prednisone, oral cyclophosphamide may be given at 1 to 2 mg/kg daily for 8 to 12 weeks.PubMedPubMedManagement of Adult Minimal Change Disease - PMC - NIH Discuss infertility risk and cumulative alkylator exposure before prescribing, particularly in patients with future reproductive plans.

During cyclophosphamide treatment, obtain weekly white blood cell counts and adjust or interrupt dosing to prevent leukopenia, defined in this approach as white blood cell count below 3,000/mm3 or neutrophil count below 1,500/mm3.PubMedPubMedManagement of Adult Minimal Change Disease - PMC - NIH

Calcineurin inhibitors are another remission-induction and steroid-sparing approach, but nephrotoxicity is a key tradeoff. Evidence synthesis supports calcineurin inhibitors and enteric-coated mycophenolate sodium, with or without reduced-dose prednisolone, as potentially effective for remission in adults; optimal agent, dose, duration, and management of relapsing or prednisolone-resistant disease remain uncertain.PubMedPubMedInterventions for minimal change disease in adults with nephrotic syndrome

Rituximab has been used in adults with steroid-dependent MCD and is recognized among treatment options for refractory disease, but randomized trial data in adults were still awaited in the cited systematic review. Use it as a specialist-directed option when relapse burden or toxicity makes conventional approaches unsuitable.PubMed+1PubMedInterventions for minimal change disease in adults with nephrotic syndromePubMedManagement of Adult Minimal Change Disease - PMC - NIH

At each follow-up, measure proteinuria, serum creatinine, blood pressure, weight, and edema burden. Resolution of proteinuria is clinically meaningful in primary podocytopathies, whereas nonresolution is associated with poor renal prognosis.NatureNaturePodocytopathies | Nature Reviews Disease Primers

Reconsider the diagnosis when proteinuria persists despite an adequate glucocorticoid exposure, kidney function deteriorates, or urine sediment becomes active. A biopsy pattern of FSGS, immune deposits, or a nephritic sediment should redirect evaluation and treatment away from uncomplicated MCD.spj science+3spj scienceAutoantibodies Targeting Vinculin Reveal Novel Insight into the Mechanisms of Autoimmune PodocytopathiesNaturePodocytopathies | Nature Reviews Disease PrimersPubMedNephrotic Syndrome - StatPearls - NCBI BookshelfPubMedChronic Kidney Disease - StatPearls - NCBI Bookshelf

For patients receiving prolonged corticosteroids, continue surveillance for infection and document weight and blood pressure. For cyclophosphamide, weekly blood counts are required during therapy; for calcineurin inhibitor-based treatment, monitor kidney function because nephrotoxicity is a recognized limitation.PubMed+2PubMedManagement of Adult Minimal Change Disease - PMC - NIHPubMedNephrotic Syndrome - StatPearls - NCBI Bookshelfcdn clinicaltrials[PDF] ACTH for Frequently Relapsing and Steroid Dependent Nephrotic ...